SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 110 filers reported holding SUTRO BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 1.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,454 | -35.6% | 2,148 | -13.7% | 0.00% | – |
| Q2 2023 | $11,579 | -20.3% | 2,490 | -20.8% | 0.00% | – |
| Q1 2023 | $14,525 | -79.8% | 3,144 | -64.0% | 0.00% | – |
| Q1 2022 | $72,000 | +94.6% | 8,740 | +251.3% | 0.00% | – |
| Q4 2021 | $37,000 | -28.8% | 2,488 | -9.2% | 0.00% | – |
| Q3 2021 | $52,000 | +4.0% | 2,741 | +2.5% | 0.00% | – |
| Q2 2021 | $50,000 | -15.3% | 2,674 | +4.0% | 0.00% | – |
| Q1 2021 | $59,000 | – | 2,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,824,542 | $39,611,000 | 19.08% |
| Samsara BioCapital, LLC | 1,675,579 | $36,377,000 | 3.66% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 185,000 | $4,016,000 | 2.33% |
| Affinity Asset Advisors, LLC | 200,000 | $4,342,000 | 2.30% |
| Altium Capital Management LP | 276,719 | $6,008,000 | 2.24% |
| FRAZIER MANAGEMENT LLC | 1,001,421 | $21,741,000 | 1.67% |
| BVF INC/IL | 1,854,162 | $40,254,000 | 1.58% |
| Asymmetry Capital Management, L.P. | 157,583 | $3,421,000 | 1.56% |
| Parkman Healthcare Partners LLC | 266,645 | $5,789,000 | 1.48% |
| AJU IB Investment Co., Ltd. | 175,000 | $3,799,000 | 1.44% |